Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: Sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants

Toxicology and Applied Pharmacology

Volumn 224, Issue 1, 2007, Pages 98-104

  Vose, Sarah C ^a,b   Holland, Nina T ^b   Eskenazi, Brenda ^b   Casida, John E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erythrocytes; Lysophosphatidylcholine; Lysophosphatidylcholine hydrolase; Neuropathy target esterase; Organophosphorus

Indexed keywords

ALKYL GROUP; HYDROLASE; INSECTICIDE; LYSOPHOSPHATIDYLCHOLINE; ORGANOPHOSPHORUS COMPOUND;

AGRICULTURAL WORKER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYDROLYSIS; IC 50; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MALE; MOUSE; NEUROPATHY; NEUROTOXICITY; NONHUMAN;

ACETYLCHOLINESTERASE; ADULT; AGRICULTURAL WORKERS' DISEASES; ANIMALS; ARYLDIALKYLPHOSPHATASE; BRAIN; ERYTHROCYTES; FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; INSECTICIDES; LYMPHOCYTES; MICE; NEUROTOXINS; ORGANOPHOSPHORUS COMPOUNDS; PREGNANCY; SUBSTRATE SPECIFICITY;

MUS;

EID: 34548623703     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.06.008     Document Type: Article

References (44)

1. Augustinsson K.-B., and Barr M. Age variation in plasma arylesterase activity in children. Clin. Chim. Acta 8 (1963) 568-573
2. Ballantyne B., and Salem H. Occupational toxicology and occupational hygiene aspects of organophosphate and carbamate anticholinesterases with particular reference to pesticides. In: Gupta R.C. (Ed). Toxicology of Organophosphate & Carbamate Compounds (2006), Elsevier, San Diego 567-595
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
4. California Department of Pesticide Regulation. California Pesticide Information Portal, Pesticide Use Reporting, 2002. http://calpip.cdpr.ca.gov/cfdocs/calpip/prod/main.cfm. Accessed July 2004.
5. Casida J.E., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 17 (2004) 983-998
6. 35S]t-butylbicyclophosphorothionate receptor and coupled components of the GABA receptor-ionophore complex in brains of human, cow, rat, chicken and fish. Life Sci. 35 (1984) 1755-1762
7. Cole T.B., Jampsa R.L., Walter B.J., Arndt T.L., Richter R.J., Shih D.M., Tward A., Lusis A.J., Jack R.M., Costa L.G., and Furlong C.E. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13 (2003) 357-364
8. 2 reveals a novel topology and catalytic mechanism. Cell 97 (1999) 349-360
9. Devedjiev Y., Dauter Z., Kuznetsov S.R., Jones T.L.Z., and Derewenda Z.S. Crystal structure of the human acyl protein thioesterase I from a single X-ray data set to 1.5 Å. Structure 8 (2000) 1137-1146
10. Ehrich M., and Jortner B.S. Organophosphorus-induced delayed neuropathy. In: Krieger R.I. (Ed). Handbook of Pesticide Toxicology vol. 2 (2001), Academic Press, San Diego 987-1012
11. Eskenazi B., Bradman A., and Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ. Health Perspect. 107 (1999) 409-419
12. Eskenazi B., Harley K., Bradman A., Weltzien E., Jewell N.P., Barr D.B., Furlong C.E., and Holland N.T. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ. Health Perspect. 112 (2004) 1116-1124
13. Eskenazi B., Marks A.R., Bradman A., Harley K., Barr D.B., Johnson C., Morga N., and Jewell N.P. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect. 115 (2007) 792-798
14. Furlong C.E., Richter R.J., Seidel S.L., and Motulsky A.G. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet. 42 (1988) 230-238
15. Furlong C.E., Holland N., Richter R.J., Bradman A., Ho A., and Eskenazi B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet. Genomics 16 (2006) 183-190
16. Geldmacher-von Mallinckrodt M., and Diepgen T.L. The human serum paraoxonase- polymorphism and specificity. Toxicol. Environ. Chem. 18 (1988) 79-196
17. Holland N., Furlong C., Bastaki M., Richter R., Bradman A., Huen K., Beckman K., and Eskenazi B. Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns. Environ. Health Perspect. 114 (2006) 985-991
18. Johnson M.K., and Glynn P. Neuropathy target esterase. In: Krieger R.I. (Ed). Handbook of Pesticide Toxicology vol. 2 (2001), Academic Press, San Diego 953-965
19. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 21 (1992) 465-487
20. Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., and Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch. Toxicol. 59 (1986) 176-179
21. Mulder E., van den Berg J.W.O., and van Deenen L.L.M. Metabolism of red-cell lipids: II. Conversions of lysophosphoglycerides. Biochim. Biophys. Acta 106 (1965) 118-127
22. Mutch E., Blain P.G., and Williams F.M. Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum. Exp. Toxicol. 11 (1992) 109-116
23. National Research Council. Pesticides in the Diets of Infants and Children (1993), National Academy Press, Washington
24. Neri M., Bonassi S., Knudsen L.E., Sram R.J., Holland N., Ugolini D., and Merlo D.F. Children's exposure to environmental pollutants and biomarkers of genetic damage: I. Overview and critical issues. Mutat. Res. 612 (2006) 1-13
25. Perera F.P., Rauh V., Tsai W.-Y., Kinney P., Camann D., Barr D., Bernet T., Garfinkel R., Tu Y.-H., Diaz D., Dietrich J., and Whyatt R.M. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ. Health Perspect. 111 (2003) 201-205
26. Popp-Snijders C., Schouten J.A., van Blitterswijk W.J., and van der Veen E.A. Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim. Biophys. Acta 854 (1986) 31-37
27. Quistad G.B., and Casida J.E. Lysophospholipase inhibition by organophosphorus toxicants. Toxicol. Appl. Pharmacol. 196 (2004) 319-326
28. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., and Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7983-7987
29. Quistad G.B., Klintenberg R., and Casida J.E. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Toxicol. Sci. 86 (2005) 291-299
30. Quistad G.B., Liang S.N., Fisher K.J., Nomura D.K., and Casida J.E. Each lipase has a unique sensitivity profile for organophosphorus inhibitors. Toxicol. Sci. 91 (2006) 166-172
31. Rauh V.A., Garfinkel R., Perera F.P., Andrews H.F., Hoepner L., Barr D.B., Whitehead R., Tang D., and Whyatt R.W. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics 118 (2006) 1845-1859
32. Richards P.G., Johnson M.K., and Ray D.E. Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 58 (2000) 577-583
33. Ross B.M., and Kish S.J. Characterization of lysophospholipid metabolizing enzymes in human brain. J. Neurochem. 63 (1994) 1839-1848
34. Rydel T.J., Williams J.M., Krieger E., Moshiri F., Stallings W.C., Brown S.M., Pershing J.C., Purcell J.P., and Alibhai M.F. The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a ser-asp catalytic dyad. Biochemistry 42 (2003) 6696-6708
35. 31P-NMR evidence for lysophospholipase. Eur. J. Biochem. 212 (1993) 411-416
36. Shohet S.B., and Beutler E. The red cell membrane. In: Williams W.J., Beutler E., Erslev A.J., and Lichtman M.A. (Eds). Hematology. 3rd ed. (1983), McGraw-Hill, New York 345-353
37. In: Tomlin C.D.S. (Ed). The Pesticide Manual. 13th ed. (2003), British Crop Protection Council, Alton, Hampshire, UK
38. van Tienhoven M., Atkins J., Li Y., and Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J. Biol. Chem. 23 (2002) 20942-20948
39. Wang A., and Dennis E.A. Mammalian lysophospholipases. Biochim. Biophys. Acta 1439 (1999) 1-16
40. Wang A., Loo R., Chen Z., and Dennis E.A. Regiospecificity and catalytic triad of lysophospholipase I. J. Biol. Chem. 272 (1997) 22030-22036
41. Wijeyesakere S.J., Richardson R.J., and Stuckey J.A. Modeling the tertiary structure of the patatin domain of neuropathy target esterase. Protein J. 26 (2007) 165-172
42. Wu S.-Y., and Casida J.E. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicol. Appl. Pharmacol. 139 (1996) 195-202
43. Young J.G., Eskenazi B., Gladstone E.A., Bradman A., Pederson L., Johnson C., Barr D.B., Furlong C.E., and Holland N.T. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology 26 (2005) 199-209
44. 1 macrophage-like cell line. Methods Enzymol. 197 (1991) 456-468